Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection

Journal of Heart and Lung Transplantation

Volumn 30, Issue 1, 2011, Pages 86-94

  Franz, Marcus ^a   Berndt, Alexander ^a   Grn, Katja ^a   Richter, Petra ^a   Kosmehl, Hartwig ^b   Neri, Dario ^c   Gummert, Jan ^d   Figulla, Hans R ^a   Brehm, Bernhard R ^a   Renner, Andre ^a,d  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

^c ETH ZURICH   (Switzerland)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

antibody; chronic rejection; drug carrier; ED A+ fibronectin; rat heart transplantation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD45 ANTIGEN; EXTRA DOMAIN A; FIBRONECTIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; DRUG DELIVERY SYSTEMS; FIBRONECTINS; FIBROSIS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION; VASCULAR DISEASES;

EID: 78149466766     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.015     Document Type: Article

References (49)

1. J.D. Hosenpud, G.D. Shipley, and C.R. Wagner Cardiac allograft vasculopathy: current concepts, recent developments, and future directions J Heart Lung Transplant 11 1992 9 23
2. M.E. Russell, M. Fujita, M.A. Masek, R.A. Rowan, and M.E. Billingham Cardiac graft vascular disease Nonselective involvement of large and small vessels Transplantation 56 1993 1599 1601 (Pubitemid 24018849)
3. C. Shi, W.S. Lee, and Q. He Immunologic basis of transplant-associated arteriosclerosis Proc Natl Acad Sci U S A 93 1996 4051 4056
4. M. Weis, and W. von Scheidt Cardiac allograft vasculopathy: a review Circulation 96 1997 2069 2077
5. H.O. Ventura, M.R. Mehra, F.W. Smart, and D.D. Stapleton Cardiac allograft vasculopathy: current concepts Am Heart J 129 1995 791 799
6. G. Sarno, A. Lerman, and J.H. Bae Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition Nat Clin Pract Cardiovasc Med 6 2009 61 69
7. G. Hausdorf, N.R. Banner, A. Mitchell, A. Khaghani, M. Martin, and M. Yacoub Diastolic function after cardiac and heart-lung transplantation Br Heart J 62 1989 123 132
8. J.G. Pickering, and D.R. Boughner Fibrosis in the transplanted heart and its relation to donor ischemic time Assessment with polarized light microscopy and digital image analysis Circulation 81 1990 949 958
9. A.T. Armstrong, P.F. Binkley, P.B. Baker, P.D. Myerowitz, and C.V. Leier Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation J Am Coll Cardiol 32 1998 704 710
10. F.G. Spinale, M.L. Coker, C.V. Thomas, J.D. Walker, R. Mukherjee, and L. Hebbar Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function Circ Res 82 1998 482 495
11. F.G. Spinale Matrix metalloproteinases: regulation and dysregulation in the failing heart Circ Res 90 2002 520 530
12. F.T. Bosman, and I. Stamenkovic Functional structure and composition of the extracellular matrix J Pathol 200 2003 423 428
13. E. Herpel, S. Singer, and C. Flechtenmacher Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies Virchows Arch 446 2005 369 378
14. U. Gabler, A. Berndt, and H. Kosmehl Matrix remodelling in dilated cardiomyopathy entails the occurrence of oncofetal fibronectin molecular variants Heart 75 1996 358 362
15. H.E. Kim, S.S. Dalal, E. Young, M.J. Legato, M.L. Weisfeldt, and J. D'Armiento Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 2000 857 866
16. D.J. Schupp, B.P. Huck, and J. Sykora Right ventricular expression of extracellular matrix proteins, matrix-metalloproteinases, and their inhibitors over a period of 3 years after heart transplantation Virchows Arch 448 2006 184 194
17. A.J. Coito, J. Binder, L.F. Brown, M. de Sousa, L. Van de Water, and J.W. Kupiec-Weglinski Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats J Immunol 154 1995 2949 2958
18. J.E. Schwarzbauer Fibronectin: from gene to protein Curr Opin Cell Biol 3 1991 786 791
19. F. Farhadian, F. Contard, A. Corbier, A. Barrieux, L. Rappaport, and J.L. Samuel Fibronectin expression during physiological and pathological cardiac growth J Mol Cell Cardiol 27 1995 981 990
20. H. Kim, C.S. Yoon, and B. Rah Expression of extracellular matrix components fibronectin and laminin in the human fetal heart Cell Struct Funct 24 1999 19 26
21. L. Zardi, B. Carnemolla, and A. Siri Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon EMBO J 6 1987 2337 2342
22. S. Astrof, and R.O. Hynes Fibronectins in vascular morphogenesis Angiogenesis 12 2009 165 175
23. A.J. Coito, J. Binder, M. de Sousa, and J.W. Kupiec-Weglinski The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats Transplantation 57 1994 599 605
24. A.J. Coito, and J.W. Kupiec-Weglinski Extracellular matrix proteins in organ transplantation Transplantation 69 2000 2465 2473
25. A.J. Coito, H. Kato, R. Azimi, and J.W. Kupiec-Weglinski Chronic allograft rejection versus tolerance: a critical role for EIIIA(+) fibronectin Transplant Proc 33 2001 526 527
26. E. Trachsel, F. Bootz, M. Silacci, M. Kaspar, H. Kosmehl, and D. Neri Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis Arthritis Res Ther 9 2007 R9
27. A. Villa, E. Trachsel, and M. Kaspar A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo Int J Cancer 122 2008 2405 2413
28. K. Ono, and E.S. Lindsey Improved technique of heart transplantation in rats J Thorac Cardiovasc Surg 57 1969 225 229
29. H. Yokoyama, M. Ohmi, S. Murata, T. Nakame, K. Tabayashi, and H. Mohri Proposal of a working left heart model with a heterotopic transplantation technique in rats J Heart Lung Transplant 14 1995 706 712
30. A. Renner, M.R. Sagstetter, and M.E. Gotz Heterotopic rat heart transplantation: severe loss of glutathione in 8-hour ischemic hearts J Heart Lung Transplant 23 2004 1093 1102
31. V. Lange, A. Renner, M. Sagstetter, H. Harms, and O. Elert Cardiac allograft vasculopathy after cardiac transplantation and hormone therapy: positive effects? Transplantation 82 2006 234 240
32. M.H. Yamani, M. Yousufuddin, and R.C. Starling Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 23 2004 272 276
33. E. Raichlin, B.S. Edwards, and W.K. Kremers Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation J Heart Lung Transplant 28 2009 320 327
34. M.E. Billingham, N.R. Cary, and M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group The International Society for Heart Transplantation J Heart Transplant 9 1990 587 593
35. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
36. J. Suzuki, M. Isobe, R. Morishita, and R. Nagai Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments Circ J1 74 2010 233 239
37. E.M. Manders, J. Stap, G.J. Brakenhoff, R. van Driel, and J.A. Aten Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy J Cell Sci 103 1992 857 862
38. M. Franz, T. Hansen, and L. Borsi A quantitative co-localization analysis of large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy J Oral Pathol Med 36 2007 6 11
39. V.R. Babaev, F. Porro, M.F. Linton, S. Fazio, F.E. Baralle, and A.F. Muro Absence of regulated splicing of fibronectin EDA exon reduces atherosclerosis in mice Atherosclerosis 197 2008 534 540
40. T. Dietrich, C. Perlitz, and K. Licha ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions Basic Res Cardiol 102 2007 298 307
41. T. Yoshimoto, M. Naruse, and H. Shizume Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy Atherosclerosis 145 1999 333 340
42. F.J. Villarreal, and W.H. Dillmann Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen Am J Physiol 262 1992 1861 1866
43. M. Dobaczewski, C. Gonzalez-Quesada, and N.G. Frangogiannis The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction J Mol Cell Cardiol 48 2010 504 511
44. J. Nozynski, M. Zakliczynski, and E. Zembala-Nozynska Remodeling of human transplanted myocardium in ten-year follow-up: a clinical pathology study Transplant Proc 39 2007 2833 2840
45. U. Gabler, A. Berndt, and H. Kosmehl Matrix remodelling in dilated cardiomyopathy entails the occurence of oncofetal fibronectin molecular variants Heart 75 1996 358 362
46. G. Serini, M.L. Bochaton-Piallat, and P. Ropraz The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta 1 J Cell Biol 142 1998 873 881
47. J. Suzuki, M. Isobe, R. Morishita, and R. Nagai Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments Circ J 74 2010 233 239
48. M.A. Glukhova, M.G. Frid, and B.V. Shekhonin Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent J Cell Biol 109 1989 357 366
49. E. El-Emir, J.L. Dearling, and A. Huhalov Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models Br J Cancer 96 2007 1862 1870